Table.

Laboratory Findings on Admission.

Hematology			Serology
WBC	21,700	/µL	CRP	10.64
Neutro.	89.7	%	IgG	1,557	mg/dL
RBC	227×104	/µL	IgA	322	mg/dL
Hb	9.1	g/dL	IgM	109	mg/dL
Ht	28.0	%	ANA	(-)
MCV	32.5	fL	AMA	(-)
Plt	28.1×104	/µL	HAV-IgM Ab	(-)
			HBsAg	(-)
Biochemistry			HBcAb	(-)
TP	7.0	g/dL	HCV-RNA	(-)
Alb	3.2	g/dL	HCV-Ab	(-)
T-bil	21.8	mg/dL	HEV-IgA	(-)
D-bil	16.6	mg/dL	CMV-IgM	(-)
AST	220	IU/L	CMV-IgG	(+)
ALT	27	IU/L	EBV-IgM (VCA)	(-)
LDH	324	IU/L	EBV-IgG (VCA)	(+)
ALP	669	IU/L	Anti EBNA Ab	(+)
γGTP	693	IU/L	HGF	2.66	ng/mL
T-cho	244	mg/dL	AFP	5.2	ng/mL
TG	379	mg/dL
FPG	107	mg/dL	Coagulation
BUN	11	mg/dL	PT%	39.6	%
Cre	0.37	mg/dL	PT-INR	1.61
Na	137	Meq/L	APTT	56.4	sec.
K	3.9	Meq/L	Fibrinogen	344	mg/dL
Cl	99	Meq/L	FDP	4.6	µg/mL
Fe	48	µg/dL
Ferritin	829	ng/mL	Fibrotic marker
NH3	62	µg/dL	Hyaluronic acid	14,300	ng/mL
Vitamin B12	1,090	pg/mL	Type IV collagen	1,936	ng/mL
Folic acid	2.4	ng/mL	M2BPGi	>20	C.O.I.
Endotoxin	<3.0	pg/mL

AFP: alpha fetoprotein, Alb: albumin, ALP: alkaline phosphatase, ALT: alanine aminotransferase, AMA: anti-mitochondrial antibody, ANA: antinuclear antibody, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, BUN: blood urea nitrogen, CMV: cytomegalovirus, CRP: C-reactive protein, Cre: creatinine, D-bil: direct bilirubin, EBNA: EBV nuclear antigen, EBV: Epstein-Barr virus, FDP: fibrin degradation product, γGTP: gamma glutamiltranspeptidase, HA: hepatitis A, Hb: hemoglobin, HCV: hepatitis C virus, HEV: hepatitis E virus, HGF: hepatocyte growth factor, Ht: hematocrit, LDH: lactate dehydrogenase, MCV: mean corpuslar volume, M2BPGi: Mac-2 binding protein, Plt: platelet, PT: prothrombin time, RBC: red blood cell, T-bil: total bilirubin, T-cho: total cholesterol, TG: triglyceride, TP: total protein, WBC: white blood cell